CORRECTION
Correction: Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network MetaAnalysis A. T. Cohen, M. Hamilton, A. Bird, S. A. Mitchell, X. Li, R. Horblyuk, S. Batson
The fifth authors name is spelled incorrectly. The correct name is Xiaoyan Li. The correct citation is: Cohen AT, Hamilton M, Bird A, Mitchell SA, Li X, Horblyuk R, et al. (2016) Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis. PLoS ONE 11(8): e0160064. doi:10.1371/journal.pone.0160064
Reference 1.
a11111
Cohen AT, Hamilton M, Bird A, Mitchell SA, Li S, Horblyuk R, et al. (2016) Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis. PLoS ONE 11(8): e0160064. doi: 10.1371/journal.pone.0160064 PMID: 27487187
OPEN ACCESS Citation: Cohen AT, Hamilton M, Bird A, Mitchell SA, Li X, Horblyuk R, et al. (2016) Correction: Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis. PLoS ONE 11(9): e0163386. doi:10.1371/journal.pone.0163386 Published: September 15, 2016 Copyright: © 2016 Cohen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PLOS ONE | DOI:10.1371/journal.pone.0163386 September 15, 2016
1/1